Clinical Determinants of Quality of Life in Elderly Patients with Hematological Malignancies: A Cross-Sectional Analysis
Quality of Life in Hematological Malignancies
DOI:
https://doi.org/10.5281/zenodo.14567585Keywords:
EORTC QLQ-C30, hematologic malignancy, frailty, depression, nutritionAbstract
Objective: This study evaluates the clinical factors affecting the quality of life (QoL) in elderly patients with hematological malignancies. Method: A cross-sectional, single-center study was conducted from April to September 2024, involving patients aged 65 and older with hematological malignancies. QoL was assessed using the EORTC QLQ-C30 questionnaire. Functional status was evaluated using the ECOG performance scale, activity of daily living (ADL), instrumental activity of daily living (IADL), and Clinical Frailty Scale (CFS). Nutritional status was analyzed using the Mini Nutritional Assessment (MNA-SF), and depressive symptoms were assessed with the Geriatric Depression Scale (GDS-15). Parameters were compared by gender, age (<75 years and ≥75 years), and chemotherapy status, with correlation analyses to explore relationships. Results: The study included 147 patients with a median age of 72.5 ±6.3. Significant correlations were found between functional scores and QoL indicators: negative correlations with ECOG and CFS (r=-0.336 to -0.618, p<0.001) and positive correlations with ADL and IADL scores (r=-0.336 to -0.628). Common symptoms included fatigue, nausea, and insomnia, with notable correlations to clinical parameters. Women reported worse scores in physical assessments and emotional/social functioning, experiencing higher levels of fatigue, pain, and insomnia. Conclusion: Functional disorders, depression, and nutritional status significantly impact the QoL of elderly patients with hematological malignancies, underscoring the need for a multidisciplinary health management approach.References
Zhang N, Wu J, Wang Q, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023;13(1):82. Published 2023 May 17. doi:10.1038/s41408-023-00853-3
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-376. doi:10.1093/jnci/85.5.365
Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570-579. doi:10.1200/JCO.1993.11.3.570
Shacham S. A shortened version of the Profile of Mood States. J Pers Assess. 1983;47(3):305-306. doi:10.1207/s15327752jpa4703_14
Hassan M, Abedi-Valugerdi M. Hematologic malignancies in elderly patients. Haematologica. 2014;99(7):1124-1127. doi:10.3324/haematol.2014.107557
Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922-935. doi:10.1111/j.1532-5415.1992.tb01992.x
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. doi:10.1016/0021-9681(87)90171-8
Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989-995. doi:10.1016/j.jclinepi.2012.02.018
Fayers P, Bottomley A; EORTC Quality of Life Group; Quality of Life Unit. Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer. 2002;38(suppl 4):S125-S133. doi:10.1016/s0959-8049(01)00448-8
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-655.
Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10(1):20-30. doi:10.1093/geront/10.1_part_1.20
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179-186.
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489-495. doi:10.1503/cmaj.050051
Kaiser MJ, Bauer JM, Ramsch C, et al. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009;13(9):782-788. doi:10.1007/s12603-009-0214-7
Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1-2):165-173. doi:10.1300/J018v05n01_09
Schober P, Boer C, Schwarte LA. Correlation Coefficients: Appropriate Use and Interpretation. Anesth Analg. 2018;126(5):1763-1768. doi:10.1213/ANE.0000000000002864
Yokoo M, Akechi T, Takayama T, et al. Comprehensive assessment of cancer patients' concerns and the association with quality of life. Jpn J Clin Oncol. 2014;44(7):670-676. doi:10.1093/jjco/hyu060
Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2-3):343-351. doi:10.1016/j.jad.2012.03.025
Wedding U, Koch A, Röhrig B, et al. Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy. Acta Oncol. 2008;47(1):56-62. doi:10.1080/02841860701460541
Ariestine DA, Sari NK, Rinaldi I, Abdullah M. Quality of life in older survivors of non-Hodgkin's lymphoma who received chemotherapy and related factors. J Geriatr Oncol. 2021;12(2):326-331. doi:10.1016/j.jgo.2020.09.002
Nolte S, Waldmann A, Liegl G, et al. Updated EORTC QLQ-C30 general population norm data for Germany. Eur J Cancer. 2020;137:161-170. doi:10.1016/j.ejca.2020.06.002
Stauder R, Yu G, Koinig KA, et al. Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study. Leukemia. 2018;32(6):1380-1392. doi:10.1038/s41375-018-0089-x
Köhler N, Mehnert A, Götze H. Psychological distress, chronic conditions and quality of life in elderly hematologic cancer patients: study protocol of a prospective study. BMC Cancer. 2017;17(1):700. Published 2017 Oct 25. doi:10.1186/s12885-017-3662-1
Lin RJ, Klepin HD. Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies. Hematology Am Soc Hematol Educ Program. 2019;2019(1):59-62. doi:10.1182/hematology.2019000076
van den Boogaard WMC, Komninos DSJ, Vermeij WP. Chemotherapy Side-Effects: Not All DNA Damage Is Equal. Cancers (Basel). 2022;14(3):627. Published 2022 Jan 26. doi:10.3390/cancers14030627
Leger DY, Moreau S, Signol N, et al. Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients. J Geriatr Oncol. 2018;9(1):60-67. doi:10.1016/j.jgo.2017.07.015
Albert PR. Why is depression more prevalent in women?. J Psychiatry Neurosci. 2015;40(4):219-221. doi:10.1503/jpn.150205
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Neslihan Kayahan Satış
This work is licensed under a Creative Commons Attribution 4.0 International License.
